Bibliography
- Partridge AH : Non-adherence to endocrine therapy for breast cancer.Ann. Oncol.17(2) , 183–184 (2006).
- Burstein HJ , PrestrudAA, SeidenfeldJ et al.: American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.J. Clin. Oncol.28(23) , 3784–3796 (2010).
- Henry NL , GilesJT, StearnsV: Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.Oncology (Williston Park)22(12) , 1401–1408 (2008).
- Henry NL , GilesJT, AngD et al.: Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Breast Cancer Res. Treat.111(2) , 365–372 (2008).
- Clauw DJ : Fibromyalgia: an overview.Am. J. Med.122(12 Suppl. 1) , S3–S13 (2009).
- Henry NL , BanerjeeM, BlossomD et al.: Duloxetine for treatment of aromatase inhibitor (AI)-associated musculoskeletal syndrome (AIMSS). Presented at: 33rd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 8–12 December 2010.
Websites
- American Cancer Society: Breast Cancer Facts and Figures, 2009–2010 www.cancer.org/acs/groups/content/@nho/documents/f861009final90809pdf.pdf (Accessed February282011)
- Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain http://clinicaltrials.gov/ct2/show/NCT01028352
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer http://clinicaltrials.gov/ct2/show/NCT00489411